Table 1.
General characteristics of the study group (n = 1706)
| Data | Total | Group 1 T2DM | Group 2 Non T2DM | p-value |
|---|---|---|---|---|
| [N = 1706] | [N = 680] | [N = 1026] | ||
| Age [years] | 66 ± 11 | 70 ± 10 | 63 ± 12 | < 0.001 |
| Sex: Women N [%] | 529 [31.0%] | 255 [37.5%] | 274 [26.7%] | < 0.001 |
| Duration of diabetes [years] | 8 ± 4 | – | ||
| BMI [kg/m2] | 28 ± 5 | 29 ± 5 | 27 ± 5 | < 0.001 |
| History of CAD N [%] | 739 [43.3%] | 417 [61.3%] | 322 [31.4%] | < 0.001 |
| History of myocardial infarction N [%] | 549 [32.2%] | 309 [45.4%] | 240 [23.4%] | < 0.001 |
| History of stroke N [%] | 100 [5.9%] | 57 [8.4%] | 43 [4.2%] | < 0.001 |
| AFib N [%] | 169 [9.9%] | 97 [14.3%] | 72 [7.0%] | < 0.001 |
| History of COPD N[%] | 66 [3.9%] | 31 [4.6%] | 35 [3.4%] | 0.282 |
| History of chronic kidney disease N [%] | 123 [7.2%] | 85 [12.5%] | 38 [3.7%] | < 0.001 |
| History of chronic heart failure N [%] | 242 [14.2%] | 141 [20.7%] | 101 [9.8%] | < 0.001 |
| History of PCI N [%] | 545 [31.9%] | 304 [44.7%] | 241 [23.5%] | < 0.001 |
| History of CABG N [%] | 201 [11.8%] | 132 [19.4%] | 69 [6.7%] | < 0.001 |
| Hypertension N [%] | 1161 [68.1%] | 555 [81.6%] | 606 [59.1%] | < 0.001 |
| Hypercholesterolemia N [%] | 556 [32.6%] | 286 [42.1%] | 270 [26.3%] | < 0.001 |
| Smoking N [%] | 410 [24.0%] | 104 [15.3%] | 306 [29.8%] | < 0.001 |
| Left ventricular ejection fraction – (LVEF) [%] | 42 ± 11 | 41 ± 12 | 43 ± 10 | < 0.001 |
Data are presented as mean ± SD
(BMI body mass index, CAD coronary artery disease, AMI acute myocardial infarction, AF atrial fibrillation, COPD chronic obstructive pulmonary disease, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, LVEF left ventricular ejection fraction)